Acknowledgements
Leukemia, MDS/AML, Cancer
LEUKEMIA, CANCER
We thank Drs. Arnaud Lesegretain, Takahiko Seki, and Prasanna Kumar from Daiichi-Sankyo Inc. for discussions and support. The study was presented in part by Jayastu Senapati at the European Hematology Association Meeting 2022, Vienna, Austria. This research is supported in part by the NCI-sponsored Leukemia SPORE grant CA100632, the Flow Cytometry & Cellular Imaging Core Facility, supported by the NCI Cancer Center Support Grant CA016672 and a Shared Instrumentation Award from the Cancer Prevention Research Institution of Texas (CPRIT), RP121010, support from Daiichi-Sankyo Inc., the MD Anderson Moon Shot program in MDS/AML and NCI R21 (CA267401).